Cardiac-specific loss of mitoNEET expression is linked with age-related heart failure

Takaaki Furihata1, Shingo Takada1, Naoya Kakutani1

  • 1Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Communications Biology
|January 30, 2021
PubMed

Insights

Mitochondrial protein MitoNEET (encoded by CISD1) is downregulated in aging hearts, leading to cardiac dysfunction and heart failure (HF) in mice. This discovery reveals a novel molecular basis for age-associated HF.

Area of Science:

  • Cardiology
  • Mitochondrial Biology
  • Aging Research

Background:

  • Heart failure (HF) is common in older adults, often associated with cardiac mitochondrial dysfunction.
  • The specific molecular mechanisms linking aging and cardiac mitochondrial decline remain incompletely understood.

Purpose of the Study:

  • To investigate the role of mitochondrial outer membrane protein MitoNEET, encoded by CDGSH iron sulfur domain 1 (CISD1), in age-associated cardiac dysfunction.
  • To elucidate the impact of CISD1 downregulation on cardiac mitochondria during aging.

Main Methods:

  • Studied cardiac-specific CISD1 deletion in C57BL/6J mice.
  • Assessed cardiac function, mitochondrial morphology, and reactive oxygen species (ROS) levels at various ages.

Main Results:

  • Cardiac-specific CISD1 deletion led to cardiac dysfunction by 12 months and heart failure by 16 months of age in mice.
  • Mitochondria in these mice exhibited irregular morphology and increased ROS levels at earlier time points.
  • MitoNEET expression was specifically downregulated in the hearts and kidneys of chronologically aged mice.

Conclusions:

  • Cardiac-specific downregulation of MitoNEET (CISD1) contributes to age-associated cardiac dysfunction and heart failure.
  • Progressive loss of mitochondrial integrity, indicated by morphology and ROS levels, is a key feature of aging hearts.
  • This study identifies a novel molecular target, CISD1/MitoNEET, implicated in the pathogenesis of age-related heart failure.

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
262
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
148
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.2K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
173
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
224
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
158